Seattle Women’s Health, Gynecology Is Now Seattle Clinical Research Center
Woman experiencing migraine

AJOVY FDA Approved for the Preventative Treatment of Migraines and is Now Available in Pharmacies

On September 14, 2018 the FDA approved AJOVY (fremanezumab-vfrm) injection for the preventative treatment of migraines in adults. The medication is an injectable calcitonin-gene-related peptide (CGRP) antagonist. This is the second anti-CGRP treatment that has recently been approved. This treatment is available in both quarterly and monthly injections. AJOVY can be self-administered or administered in … Read more

Softball girl's high fiving

FDA Approves Qbrexza Cloth for the Treatment of Hyperhidrosis

Seattle Clinical Research Center is pleased to announce that the FDA has approved a new treatment for axillary hyperhidrosis, also known as excessive underarm sweating. This is a chronic skin condition that affects approximately 10 million people in the United States and causes people to sweat more than what is necessary for normal thermal regulation. … Read more

Woman suffering with migraine

FDA Approves New Migraine Medication

Seattle Clinical Research Center is excited to announce that the FDA has approved Aimovig, a new treatment developed specifically for migraine headache prevention. Migraine is a debilitating condition that impacts 38 million patients in the United States. Seattle Clinical Research Center conducted one of the pivotal clinical trials involved in the approval process. Aimovig is … Read more

Woman experiencing pain during sex

Intrarosa for Postmenopausal Women Experiencing Pain During Sex Now Available in Pharmacies

Intrarosa (prasterone) was recently FDA approved to treat moderate to severe painful sexual intercourse (dyspareunia) caused by vulvar and vaginal atrophy (VVA). VVA is a common condition affecting up to 50% of postmenopausal women that results from the loss of estrogen during menopause. This causes the walls of the vagina and surrounding tissues to become … Read more

WE'RE MOVING APRIL 2024